IRulya Therapeutics Inc. vs Pulike Biological Engineering, Inc.
Market value, revenue, profit, valuation and financial strength side by side, each from the company's own filings or market data, with its date.
In short
- Pulike Biological Engineering, Inc. is the larger company by market value: $524 M against $343 M for IRulya Therapeutics Inc., 1.5 times as much (market caps of Oct 30, 2026 for IRulya Therapeutics Inc. and Aug 1, 2026 for Pulike Biological Engineering, Inc.). Pulike Biological Engineering, Inc.'s value is the last on file, from Aug 1, 2026: no market-data feed is connected for its exchange yet.
Market value, the same start = 100
From Jan 2020: how each one's value moved, whatever its size.
Side by side
| Measure | IRulya Therapeutics Inc. IRLA · #14,199 in the world | Pulike Biological Engineering, Inc. 603566.SS · #12,321 in the world |
|---|---|---|
| Profile | ||
| Country | 🇺🇸 USA | 🇨🇳 China |
| Sector | Healthcare | Healthcare |
| Industry | Biotechnology | Biotechnology |
| Founded | — | — |
| Size | ||
| Market cap | $343 M | $524 M |
| Net income | $-84 M | — |
| Employees | 55 | — |
| Valuation | ||
| Free cash flow yield | -12.2% | — |
| Altman Z-score zone | — | — |
| Data as of | Market cap Oct 2026; ratios FY2025 | Market cap Aug 2026 |
Questions and answers#
Which is bigger, IRulya Therapeutics Inc. or Pulike Biological Engineering, Inc.?
Pulike Biological Engineering, Inc. is the larger company by market value: $524 M against $343 M for IRulya Therapeutics Inc., 1.5 times as much (market caps of Oct 30, 2026 for IRulya Therapeutics Inc. and Aug 1, 2026 for Pulike Biological Engineering, Inc.). Pulike Biological Engineering, Inc.'s value is the last on file, from Aug 1, 2026: no market-data feed is connected for its exchange yet.